R-Pola-Glo

  • Andraschko, Diana (Researcher)
  • Rauscher, Isabella (Researcher)
  • Schmitt, Clemens (PI)

Project: Clinical studies › Clinical Study (Industry project)

Project Details

Description

A prospective multicenter phase 2 study of the chemotherapy-light combination of intravenous rituximab with the antibody-drug conjugate polatuzumab vedotin and the bispecific antibody glofitamab in previously untreated aggressive B-cell lymphoma patients above 60 years of age ineligible for a fully dosed R-CHOP
StatusActive
Effective start/end date07.08.2023 → 03.01.2028

Collaborative partners

  • Johannes Kepler University Linz (lead)
  • Institut für Klinische Krebsforschung IKF GmbH (Project partner)
  • Arbeitsgemeinschaft Medikamentöse Tumortherapie gGmbH (Project partner)

Fields of science

  • 302024 Haematology
  • 302055 Oncology